12:00 AM
 | 
Oct 22, 2007
 |  BC Week In Review  |  Company News  |  Deals

Cardiff Biologicals Ltd., Cardiff, Morvus deal

Eli Lilly and Co. (LLY, Indianapolis, Ind.) markets Gemzar gemcitabine to treat breast cancer, non-small cell lung cancer (NSCLC) and pancreatic cancer, and advanced relapsed ovarian cancer in...

Read the full 139 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >